Top Section/Ad
Top Section/Ad
Most recent
M&A could be much needed shot in the arm but dollars expected to dominate
Deal includes $1bn 3.75 year term loan
The German pharmaceutical wholesaler was upgraded to BBB- by S&P last month
US drug company Eli Lilly jolted the dollar market awake on Wednesday with an eight-part jumbo trade to fund two recent acquisitions
More articles/Ad
More articles/Ad
More articles
-
Smaller, privately owned companies are becoming a key part of the local IPO market -
Government interventions staved off pandemic-related defaults, though macro headwinds are causing uncertainty
-
Verona Pharma and Borr Drilling raise capital at opportune moment
-
Finances drug company's buyout by Carlyle and PAI Partners
-
UK blocks have been few and far between in recent months
-
GSK’s consumer health business trades down on London debut
